Physician profile
Joshua A Lemmon
NPI 1649498171
$118,428.21
in general payments reported to CMS, 2019-2025
21 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $14K · 2021: $23K · 2022: $26K · 2023: $3,772 · 2024: $9,638 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $4,603 · Travel and Lodging: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,150.00 |
| Food and Beverage | $4,602.75 |
| Travel and Lodging | $497.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $104,811.07 | 2019-2025 | Molli, Dermacell, 1788 |
| Axogen | $4,701.48 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Rti Surgical, INC | $4,156.59 | 2021-2025 | |
| Davol INC. | $1,206.47 | 2019-2025 | Phasix Mesh |
| Abbvie INC. | $1,203.08 | 2023-2025 | |
| Dilon Technologies, INC. | $525.65 | 2023-2025 | Hemoblast Bellows |
| Allergan, INC. | $491.82 | 2019-2022 | |
| Sientra, INC. | $421.48 | 2021-2022 | |
| Mentor Worldwide LLC | $215.16 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Mimedx Group, INC. | $158.73 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $146.85 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $119.86 | 2025 | Phasix Mesh |
| Bone Support INC. | $72.42 | 2024 | Ceramentbone Void Filler, Cerament G |
| Baxter Healthcare | $45.48 | 2021-2023 | |
| Medtronic, INC. | $32.57 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $25.10 | 2025 | Novosorb Btm |
| Heron Therapeutics, INC. | $24.83 | 2025 | Zynrelef |
| Sanara Medtech INC. | $23.51 | 2021 | |
| Apyx Medical Corporation | $18.56 | 2020 | |
| Cook Medical LLC | $13.97 | 2022 | |
| Smith+Nephew, INC. | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lemmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.